| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1c0bb1c00c1bdb4111cd08218273f10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed32ea6d1038655bee92d184e83776cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-06 |
| filingDate |
2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6eae720132abb8eb8016888a01fa26c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_307e285d4c902857717dec8f88cc6d03 |
| publicationDate |
2007-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007002493-A2 |
| titleOfInvention |
Compositions and methods for modulating the acute phase response |
| abstract |
Methods and compositions are provided for modulating the acute phase response. In particular, methods and compositions are provided that inhibit the acute phase response, including expression or production of C-reactive protein (CRP). The invention accordingly has applicability to the modulation of innate immune responses and to cardiovascular diseases and disorders, particularly atherosclerosis. The instant methods and compositions are based on the discovery that the mammalian transcription factor CREBH is necessary for the induction of an acute phase response and/or an innate immune response. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8632838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10117974-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096703-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8197471-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9764069-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895470-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016532-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8308699-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8574660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012112547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111387142-A |
| priorityDate |
2005-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |